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Between 2014 and 2015, the Klebsiella pneumoniae carbapenemase (KPC) was
becoming endemic in South Korea. To assess this period of transition, we analyzed
KPC producers in terms of molecular epidemiology. A total of 362 KPC-producing
Enterobacteriaceae strains, including one from 2013, 13 from 2014, and 348 from 2015,
were actively collected from 60 hospitals throughout the peninsula. Subtypes of KPC
were determined by PCR and direct sequencing, and isotypes of Tn4401 (the transposon
flanking the blaKPC gene) were specified by PCR using isotype-specific primers and
direct sequencing. Sporadic occurrence of KPC-producing Enterobacteriaceae was
initially observed around Seoul, which is the most crowded district of the country,
and these strains rapidly disseminated in 2014, to the other parts of the country in
2015. The bacterial clones responsible for the extreme epidemiological transition were
K. pneumoniae ST307 (46.2%) and ST11 (21.3%). Less frequently, E. coli (4.7%),
Enterobacter spp. (1.4%), and other Enterobacteriaceae members (1.7%) producing
the enzyme were identified. The blaKPC-2 gene bracketed by Tn4401a (72.1%) was
the most prevalent mobile genetic element responsible for the dissemination, and the
same gene carried either by Tn4401b (2.2%) or Tn4401c (6.6%) was identified at a
lesser frequency. The genes blaKPC-3 (1.6%) and blaKPC-4 (6.4%), both flanked by
Tn4401b, were occasionally identified. This study showed endemic dissemination of KPC
producers in 2015 due to a clonal spread of two K. pneumoniae strains. Further systemic
surveillance is needed to monitor dissemination of KPC-producers.
Keywords: KPC, Tn4401, carbapenem resistance, Klebsiella pneumoniae ST307, carbapenemase producing
Enterobacteriaceae
INTRODUCTION
Carbapenemases often jeopardize chemotherapy for infectious diseases caused by common
nosocomial pathogens. Currently, Klebsiella pneumoniae carbapenemases (KPC) belonging to
the Ambler class A carbapenemases are the most clinically worrisome enzymes because of their
global spreads and a broad-spectrum of substrates including most of the β-lactam drugs, except
cephamycins (Munoz-Price et al., 2013; Pitout et al., 2015). KPC producers were first identified for
K. pneumoniae from the United States in 1996 (Yigit et al., 2001) and, so far, a total of 23 KPC
variants have been identified (http://www.lahey.org/Studies). KPC producers, particularly among
Enterobacteriaceae isolates, are now being extensively reported worldwide. In some regions of the
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world, such as North America (some regions of the USA), Latin
America (Colombia, Brazil, and Argentina), Europe (Greece and
Italy), the Middle East (Israel), and Asia (some regions of China),
KPC dissemination has reached endemic levels (Albiger et al.,
2015; Mehta et al., 2015).
The rapid dissemination of the blaKPC gene is known to
be derived from the clonal spread of K. pneumoniae sequence
type 258 (ST258) (Munoz-Price et al., 2013; Pitout et al., 2015).
Besides, horizontal gene transfer drives KPC dissemination via
a Tn3-type active transposon Tn4401 enclosing the blaKPC
gene. The transposon is bracketed by 39-bp imperfect inverted
repeat sequences capable of mobilizing the blaKPC gene at high
frequency and it generates a 5-bp target duplication by insertion
without target site specificity (Cuzon et al., 2011). At present,
nine isotypes of Tn4401 (Tn4401a to Tn4401i) differing by the
upstream sequences of the blaKPC gene were identified. The
blaKPC gene promoters varied by the Tn4401 isotypes control the
level of gene expression resulting in varied levels of carbapenem
resistance (Naas et al., 2012; Cheruvanky et al., 2017).
The National Laboratory Surveillance System (NLSS) for
CPEs started in November 2010 by the Korea Center for Disease
Prevention and Control (KCDC) with 100 sentinel general
hospitals (unpublished data). Through the surveillance study,
an alarming transition of KPC epidemiological stages to inter-
regional spread was observed between 2014 and 2015. The
population of KPC producers and the inter-regional movement
of core clones needed to be further investigated and, in this study,
the molecular epidemiology was assessed with actively collected
KPC producers located throughout the peninsula.
MATERIALS AND METHODS
Strains
A total of 362 non-duplicate KPC-producing Enterobacteriaceae
strains (one from 2013, 13 from 2014, and 348 from
2015) were collected voluntarily from 60 hospitals: 16 NLSS-
non-participating hospitals including 12 general hospitals,
two convalescent hospitals, and two clinics, and 44 NLSS-
participating general hospitals. Further testing including the
species identification by 16S rDNA sequencing was performed in
a reference laboratory.
Antimicrobial Susceptibility and
Resistance Analyses
Antimicrobial susceptibility to eight drugs (aztreonam,
cefotaxime, ceftazidime, cefoxitin, gentamicin, amikacin,
ciprofloxacin, and tigecycline) was evaluated by the disk
diffusion method on Mueller-Hinton (MH) agar (Difco
Laboratories, Detroit, MI), following CLSI guidelines (Clinical
and Laboratory Standards Institute, 2015b). The MICs for
colistin were assessed by the broth microdilution method using
MH broth (Difco Laboratories), following the recommendations
of the Joint CLSI-EUCAST Polymyxin Breakpoints Working
Group (The joint CLSI–EUCAST and Polymyxin Breakpoints
Working Group, 2016). TheMICs for imipenem andmeropenem
were determined by the agar dilution method, following CLSI
guidelines (Clinical and Laboratory Standards Institute, 2015a).
Both Escherichia coli ATCC 25922 and Pseudomonas aeruginosa
ATCC 27853 were used for quality control. The blaKPC gene was
detected by PCR using gene-specific primers (Supplementary
Table), and direct sequencing was carried out for subtyping
KPC. Additional resistance determinants were identified by
PCR and direct sequencing: blaCTX-M-1-like, blaCTX-M-9-like,
and blaCTX-M-25-like for CTX-M-type extended-spectrum β-
lactamases (ESBLs); blaACT, blaACC, blaCMY, and blaDHA for
plasmid-mediated AmpCs; and armA, rmtA, and rmtB for16S
ribosomal methyltransferases (Perez-Perez and Hanson, 2002;
Ryoo et al., 2005). Multiple-carbapenemase producers of positive
amplification either of blaOXA-48-like, blaIMP, blaVIM, blaGES, and
blaNDM genes were eliminated from the study.
Isotyping the Tn4401 Transposon
To determine the isotypes of Tn4401, isotype-specific forward
primers for the five most common isotypes (a to e) (Naas et al.,
2012) were newly designed (Supplementary Table) and PCR was
carried out with a universal reverse primer targeting the blaKPC
gene. The amplicons were sequenced for verification.
Multilocus Sequence Typing (MLST)
PCR and sequencing were carried out for seven housekeeping
genes: gapA, infB, mdh, pgi, phoE, rpoB, and tonB for
K. pneumoniae (Diancourt et al., 2005), and adk, fumC,
gyrB, icd, mdh, purA, and recA for E. coli (Wirth et al., 2006).
The nucleotide sequences obtained for both DNA strands were
compared with sequences in the MLST database for each species
(http://bigsdb.web.pasteur.fr/klebsiella for K. pneumoniae
and http://mlst.warwick.ac.uk/mlst/dbs/Ecoli for E. coli), to
determine allelic numbers and STs.
RESULTS
The Epidemiology of KPC-Producing
Enterobacteriaceae
Among the 362 KPC-producing Enterobacteriaceae strains,
K. pneumoniae (334/362, 92.2%) was the predominant bacterial
species and E. coli (17/362, 4.7%) was followed by Enterobacter
spp. (5/362, 1.4%), Citrobacter spp. (3/362, 0.8%), Klebsiella
oxytoca (1/362, 0.3%), Serratia marcescens (1/362, 0.3%), and
Hafnia alvei (1/362, 0.3%) were identified less frequently.
Three subtypes KPC-2 (334/362, 92.3%), KPC-3 (6/362, 1.7%),
and KPC-4 (22/362, 6.1%) were identified. Major isotype of
the Tn4401 bracketing the blaKPC gene was Tn4401a (261/362,
72.0%) and, less frequently, Tn4401b (36/362, 9.9%) and Tn4401c
(24/362, 6.6%) were identified. Tn4401b was linked with all three
subtypes of the blaKPC gene, while Tn4401a and Tn4401c carried
only the blaKPC-2 gene. For the non-isotypable 41 transposons
(11.3%) by the Tn4401-isotyping PCR, amplification between the
3′-end of the upstream ISKpn7 and the blaKPC gene was tried and
only one of the 41 was identified having a truncated Tn3 at the
isotype-determining region, while none produced any amplicons.
The non-isotype-determined (ND) Tn4401s were coupled only
with blaKPC-2 gene, whether in K. pneumoniae (n = 38) or in
E. coli (n= 3).
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The blaKPC-2 gene bracketed by Tn4401a
(Tn4401a[blaKPC-2]) was harbored by K. pneumoniae (n = 243)
of varied STs [mainly ST307 (n = 155), ST11 (n = 37), and
ST789 (n = 21)], E. coli (n = 11) [mostly of ST1624 (n = 7)],
and other Enterobacteriaceae [Enterobacter spp. (n = 2),
C. freundii (n = 2), C. koseri (n = 1), K. oxytoca (n = 1),
and S. marcescens (n = 1)] (Table 1). Tn4401b[blaKPC-2] was
carried either by K. pneumoniae (n = 7), five ST11 and two
ST307, or by Enterobacter spp. (n = 1). Tn4401c[blaKPC-2]
was carried only by K. pneumoniae (n = 24) belonging to
ST307 (n = 8), ST789 (n = 6), ST11 (n = 5), ST48 (n = 3),
ST392 (n = 1), and ST2230 (n = 1). The Tn4401b[blaKPC-3]
was identified in E. coli ST393 (n = 2) and in K. pneumoniae
(n = 4, specifically two ST314 and one each of ST15 and
ST697) and Tn4401b[blaKPC-4] was identified in K. pneumoniae
(specifically five ST392, four ST101, three ST11, two ST307,
and one of each ST4, ST48, ST54, and ST627), E. coli
ST2847 (n = 1), Enterobacter spp. (n = 2), and Hafnia alvei
(n= 1).
Dissemination of KPC Producers
throughout the South Korean Peninsula
from 2013 to 2015
One K. pneumoniae isolate ST2230/Tn4401c[blaKPC-2] was
collected in Seoul in 2013. In 2014, 13 KPC producers
were identified including six K. pneumoniae strains, i.e.,
two ST307/Tn4401a[blaKPC-2], one ST11/ND[blaKPC-2], one
ST392/Tn4401c[blaKPC-2], one ST392/Tn4401b[blaKPC-4],
and one ST15/Tn4401b[blaKPC-3], along with seven E. coli
ST1642/Tn4401a[blaKPC-2] strains from a single-hospital
outbreak in a suburb of Seoul (Incheon). In 2015, a total of 348
KPC producers were identified including 327 K. pneumoniae
[mainly ST307/Tn4401a[blaKPC-2] (153/327, 46.8%),
ST11/Tn4401a[blaKPC-2] (37/327, 11.3%), ST25/ND[blaKPC-2]
(25/327, 7.6%), and ST789/Tn4401a[blaKPC-2] (21/327, 6.4%)]
and 10 E. coli strains of nine subclones. Notably, five KPC-
producing K. pneumoniae isolates were collected in 2015
from other healthcare facilities than general hospitals:
ST307/Tn4401a[blaKPC-2], ST11/Tn4401a[blaKPC-2], and
ST290/Tn4401a[blaKPC-2]) from two convalescent hospitals and
ST48/Tn4401c[blaKPC-2] and ST307/Tn4401a[blaKPC-2] from
two clinics.
The K. pneumoniae ST307/Tn4401a[blaKPC-2],
ST11/ND[blaKPC-2], and ST392/Tn4401b[blaKPC-4] clones
were identified over two consecutive years. In 2014, two
K. pneumoniae ST307/Tn4401a[blaKPC-2] were first identified
in Seoul. In 2015, the same clone was identified with 153
strains in Seoul (n = 49) and three more districts including a
suburb of Seoul (Gyeonggi, n = 12), a southeastern peninsula
(Busan, n = 91), and a southwestern peninsula (Jeonbuk, n = 1;
Figure 1). Besides, the K. pneumoniae ST11/ND[blaKPC-2]
clone was first identified in Seoul in 2014 and, in 2015, the
same clone was identified in Seoul (n =12), two suburbs of
Seoul (Gyeonggi, n = 1; Incheon, n = 1), and in southeastern
peninsula (Gyeongbuk, n= 2; Busan, n= 1). The K. pneumoniae
ST392/Tn4401b[blaKPC-4] clone from Incheon in 2014 was
subsequently identified with four isolates in 2015 from the same
district.
Carbapenem Resistance Conferred by the
blaKPC Gene
Overall MIC50s of imipenem and meropenem in KPC producers
were 16 mg/L and 8 mg/L, respectively (Figure 2), and the values
met the three predominant factors in the KPC populations:
the host bacterial species (K. pneumoniae), the resistance gene
(blaKPC-2), and the transposon encoding the gene (Tn4401a).
The KPC-producing K. pneumoniae had three-dilution higher
MIC50s of the two carbapenems than E. coli and KPC-2
producers had three- and four-dilution higher MIC50 values
than to the KPC-3 and KPC-4 producers, respectively. The KPC
producers carrying Tn4401a had one- or two-dilution higher
MIC50 values of the carbapenemase than KPC producers carrying
Tn4401b, whereas those carrying Tn4401c had the same MIC50
values as KPC producers carrying Tn4401a. The ND transposon
encoding blaKPC-2 (n= 40) had the highestMIC50 ofmeropenem
32 mg/L that was two- to three-dilution higher than the three
isotypes of Tn4401, whereas that of imipenem looked alike.
Cross- and Co-resistance to Other Drugs
As a result of cross resistance from producing KPC, all or most
of the 362 KPC producers were non-susceptible to aztreonam
(100%), cefotaxime (100%), ceftazidime (n = 359, 99.2%), and
cefoxitin (n= 325, 89.8%) (Table 2).
A total of 192 KPC producers (53.0%) produced at least one
CTX-M-type ESBL (Table 3): 46.7% (169/362) CTX-M type 1
and 8.0% (29/362) CTX-M type 9. Of note, the blaCTX−M gene
was often possessed by KPC-2 (183/334, 54.8%) and KPC-4
(9/22, 40.9%) producers, whereas none were identified in KPC-
3 producers. Plasmid-mediated AmpC was rarely co-produced
(13/362, 3.4%) by the KPC producers: DHA (n= 9), ACT (n= 1),
or CMY (n= 1) production in KPC-2 producers andACC (n= 2)
production in KPC-4 producers.
Among the 362 KPC producers, 220 (60.8%) and 46
(12.7%) were resistant to gentamicin and amikacin, respectively,
but only few KPC-2 producers possessed the 16S ribosomal
methyltransferase armA (1/362, 0.3%) and rmtB (22/362, 6.1%)
genes.
A total of 348 isolates (96.7%) were non-susceptible to
ciprofloxacin and 80 (22.1%) and eight (2.2%) isolates were non-
susceptible to tigecycline and colistin, respectively. None of the
eight colistin-resistant strains possessed themcr gene.
DISCUSSION
KPC enzymes are able to hydrolyze penicillins, cephalosporins,
monobactams, carbapenems, and even β-lactamase inhibitors.
Therefore, the wide spread of the producers is one of the
worrisome global issues encountering antimicrobial resistance.
In accordance of occasional reports (Rhee et al., 2010; Hong et al.,
2013; Yoo et al., 2013) and data from NLSS (unpublished data),
only infrequent occurrence of the KPC producers were identified
in South Korea until 2013. However, after a sudden expansion
of KPC producers in 2014, rapid nation-wide spread supported
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FIGURE 1 | Appearance and inter-regional dissemination of KPC producers carrying varied Tn4401 isotypes between 2013 and 2015. Colored dots indicate the
subtypes of the blaKPC gene and isotypes of Tn4401 that were located in each district. The size of each dot represents the number of isolates on a log scale.
Inter-regional dissemination of the two KPC-producing clones is denoted with broken arrows.
FIGURE 2 | MICs of imipenem (A) and meropenem (B) in KPC producers. Boxplots present MIC50, MIC10, and MIC90 values, with whiskers showing the maximum
and minimum MICs of the group.
by single-hospital outbreaks (Kim et al., 2017), frequently
associated with inter-hospital or inter-regional spread (Jeong
et al., 2016) led the endemic stage of KPC in 2015. Actually,
the KPC producer in 2013 has never been identified again and
the four K. pneumoniae subclones, ST307/Tn4401a[blaKPC-2],
ST307/Tn4401b[blaKPC-4], ST392/Tn4401b[blaKPC-4], and
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TABLE 2 | Resistance phenotypes of KPC producers.
Total Number (%) of non-susceptible strains to
Aztreonam Cefotaxime Ceftazidime Cefoxitin Gentamicin Amikacin Ciprofloxacin Tigecycline Colistin
KPC-2 334 334 (100) 334 (100) 332 (99.4) 305 (91.3) 203 (60.8) 44 (13.2) 323 (96.7) 77 (23.1) 8 (2.4)
Tn4401a 261 261 (100) 261 (100) 259 (99.2) 235 (90.0) 160 (61.3) 17 (6.5) 250 (95.8) 72 (27.6) 4 (1.5)
Tn4401b 8 8 (100) 8 (100) 8 (100) 8 (100) 8 (100) 5 (62.5) 8 (100) 0 (0.0) 1 (12.5)
Tn4401c 24 24 (100) 24 (100) 24 (100) 22 (91.7) 12 (50.0) 2 (8.3) 24 (100) 4 (16.7) 1 (4.2)
ND 41 41 (100) 41 (100) 41 (100) 40 (97.6) 23 (56.1) 20 (48.8) 41 (100) 1 (2, 0.4) 2 (4.9)
KPC-3 6 6 (100) 6 (100) 5 (83.3) 6 (100) 2 (33.3) 0 (0.0) 6 (100) 0 (0.0) 0 (0.0)
Tn4401b 6 6 (100) 6 (100) 5 (83.3) 6 (100) 2 (33.3) 0 (0.0) 6 (100) 0 (0.0) 0 (0.0)
KPC-4 22 22 (100) 22 (100) 22 (100) 14 (63.6) 15 (68.2) 2 (9.1) 19 (86.4) 3 (13.6) 0 (0.0)
Tn4401b 22 22 (100) 22 (100) 22 (100) 14 (63.6) 15 (68.2) 2 (9.1) 19 (86.4) 3 (13.6) 0 (0.0)
Total 362 362 (100) 362 (100) 359 (99.2) 325 (89.8) 220 (60.8) 46 (12.7) 348 (96.1) 80 (22.1) 8 (2.2)
TABLE 3 | Co-producing drug CTX-M-type extended-spectrum beta-lactamase.
Total CTX-M-type extended-spectrum beta-lactamase
Type 1 Type 9 Both types 1
and 9
KPC-2 334 156 (46.7) 21 (6.3) 6 (1.8)
Tn4401a 261 136 (52.1) 9 (3.4) 6 (1.8)
Tn4401b 8 2 (25.0) 1 (12.5) 0 (0.0)
Tn4401c 24 5 (20.8) 0 (0.0) 0 (0.0)
ND 41 13 (31.7) 11 (26.8) 0 (0.0)
KPC-3 6 0 (0.0) 0 (0.0) 0 (0.0)
Tn4401b 6 0 (0.0) 0 (0.0) 0 (0.0)
KPC-4 22 7 (31.8) 2 (9.1) 0 (0.0)
Tn4401b 22 7 (31.8) 2 (9.1) 0 (0.0)
Total 362 163 (45.0) 23 (6.4) 6 (1.7)
ST11/ND[blaKPC-2] in 2014 triggered the inter-regional
dissemination of KPC producers.
In agreement with the Healthcare Delivery System in South
Korea, convalescent hospitals are in charge post-acute care and
general hospitals are responsible for acute care, leading a habitual
inter-hospital patient transfer. In general, the infection control
system in convalescent hospitals is poorly operated compared to
that in general hospitals and their role as a reservoir of CPE has
been highly suspected. Indeed, the core KPC-producing subclone
K. pneumoniae ST307/Tn4401a[blaKPC-2] was identified in all
three types of healthcare facilities: 153 of the 362 KPC producers
from general hospitals, one of the three isolates from the two
convalescent hospitals and one of the two isolates from clinics.
It suggested that the KPC has disseminated during the inter-
hospital patient transfer and expanded up to the community
level. Further study with more isolates from the two types of
healthcare facility is needed.
The well-known KPC-producing clone in a global level is
K. pneumoniae ST258 (Pitout et al., 2015; Sheppard et al., 2016),
however, it was not the case in South Korea. The foremost
South Korean KPC producer was K. pneumoniae ST307 clone
and the ST11 was followed by presenting half the prevalence of
ST307. Indeed, the ST258 (gapA-infB-mdh-pgi-phoE-rpoB-tonB,
3-3-1-1-1-1-79) is a deduced variant of ST11 (3-3-1-1-1-1-43)
manufactured by multiple events of a genetic rearrangement
(Breurec et al., 2013). K. pneumoniae ST307, which has gained
attention as a potentially high-risk KPC producer, has been a
notorious clone producing CTX-M-15 (Villa et al., 2017) and the
clone co-producing KPC and CTX-M-15 was recently identified
in Italy (Geraci et al., 2015). The South Korean ST307 clone
are assumed to be close to the Italian clone in an evidence
of 71.9% KPC-producing K. pneumoniae ST307 co-produced
CTX-M enzyme. The second-most disseminated K. pneumoniae
ST11 is one of the main KPC-producing clones in China, and it
frequently co-harbors the rmtB genes (Cheng et al., 2016). The 22
RmtB-co-producers were all K. pneumoniae ST11 representing
28.7% (22/77) the clone.
KPC-2 and KPC-3 are the prevailing global subtypes of KPC,
with regional variation (Munoz-Price et al., 2013). Among the
South Korean KPC producers, KPC-4 was the second most
prevalent subtype, although the number of KPC-4 producers was
only one fifteenth that of the KPC-2 producers. Since the bacterial
host species varied, the Tn4401b-associated plasmid (along with
sporadic occurrence) was likely responsible for its observed
dissemination. KPC-3, which was produced by fewer bacterial
hosts, was limited to one district. KPC-2, KPC-3, and KPC-4
each confer a similar level of carbapenem resistance (Mehta et al.,
2015). However, among the KPC producers studied, KPC-2 had
the highest MIC50s for carbapenems, while KPC-3 and KPC-4
had 3- and 4-dilution-reduced MIC50s, respectively (Figure 2). It
is likely that multiple factors (such as small relative group size, or
low gene expression in the Tn4401b isotype) accounted for this
unexpected result.
Although group size varied (334 vs. 17), the KPC-producing
K. pneumoniae isolates had 3-dilution higher MIC50s for
carbapenems compared to the KPC-producing E. coli isolates
(Figure 2), pronouncing the importance of bacterial host
background for revealing resistance. As well, the Tn4401 isotypes,
differing the promoter of the blaKPC gene, is closely associated
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with the level of gene expression resulting in varied carbapenem
susceptibility (Naas et al., 2012; Cheruvanky et al., 2017).
For example, Tn4401a and Tn4401d possessing two promoters
upstream from the gene confer high carbapenem resistance
whereas Tn4401c and Tn4401e, with one promoter, confer low
levels of resistance and the Tn4401b, with three promoters,
confers moderate resistance (Naas et al., 2012; Cheruvanky
et al., 2017). Three isotypes of the transposon that are Tn4401a,
Tn4401b, and Tn4401c were identified in our study. Tn4401a
had the highest MIC50s for carbapenems and the Tn4401b
exhibited the lowest values. Tn4401c of similar MIC50 values
to those of Tn4401a could be explained by the bacterial host,
as K. pneumoniae likely, somehow, has the most efficient KPC
production. The relatively high meropenem MIC50 by ND
transposon encoding the blaKPC-2 compared to the other isotypes
of Tn4401 needed to be further studied.
Though the global spread of KPC-producing
Enterobacteriaceae is becoming more common, local
epidemiology patterns need to be actively assessed. An awareness
of the details of regional epidemiology is fundamental for
understanding specific situations. Most endemic cases have
occurred via the clonal dissemination of notorious KPC-
producing clones, and the South Korean situation was no
exception. The disseminated K. pneumoniae clones in South
Korea have been linked to the Italian ST307 and Chinese
ST11 strains, confirming the importance of international and
intercontinental travel for clonal spread. There remains a paucity
of antimicrobial options to treat pathogens capable of KPC
production, which raises mortality rates. Only a few new drug
candidates are in development at present. Combination therapy
using both β-lactams and β-lactamase inhibitors that are stable
in the presence of KPC enzymes (such as avibactam) is available
in other parts of the world, but is not yet accessible in South
Korea. Because South Korea is facing endemic dissemination,
the situation is critical. Only systematic surveillance will
empower researchers to control and prevent the spread of KPC
producers.
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